Bottom line
CRCA vs VOO: the short answer
CRCA (ProShares Ultra CRCL) and VOO (Vanguard 500 Index Fund) are both etfs.
But VOO is far broader, holding 520 positions to 11 for CRCA, so beyond the top names it adds exposure CRCA doesn't have.
VOO is cheaper at 0.03% vs 0.95% — a difference of $92 a year per $10,000 invested.
Updated Nov 19, 2026
CRCA vs VOO side by side
| CRCA | VOO | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ProShares | Vanguard |
| Category | Other | S&P 500 Index |
| Expense ratio | 0.95% | 0.03% |
| Annual cost per $10k | $95 | $3 |
| 10-yr cost on $10k (prospectus) | $1,231 | $39 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | — | +17.8% |
| 5-yr return (annualized) | — | +14.4% |
| 10-yr return (annualized) | — | +14.8% |
| Best quarter | — | +20.5% |
| Worst quarter | — | −19.6% |
| Net assets (fund) | $227.5M | $1.7T |
| Number of holdings | 11 | 520 |
| Portfolio turnover | % | 2% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CRCA and VOO share none of their top holdings.
CRCA top 10
- Repurchase Agreement — 6.18%
- N/a — 4.32%
- Repurchase Agreement — 3.89%
- Repurchase Agreement — 2.92%
- Repurchase Agreement — 2.14%
- N/a — 0.21%
- N/a — -2.27%
- N/a — -2.52%
- N/a — -2.98%
- N/a — -3.09%
VOO top 10
- NVIDIA Corp — 7.51%
- Apple Inc — 6.59%
- Microsoft Corp — 4.30%
- Amazon.com Inc — 3.62%
- Alphabet Inc — 3.25%
- Broadcom Inc — 2.77%
- Alphabet Inc — 2.59%
- Micron Technology Inc — 2.02%
- Meta Platforms Inc — 1.92%
- Tesla Inc — 1.84%
FAQ
What is the difference between CRCA and VOO?
CRCA (ProShares Ultra CRCL) and VOO (Vanguard 500 Index Fund) are both etfs. But VOO is far broader, holding 520 positions to 11 for CRCA, so beyond the top names it adds exposure CRCA doesn't have.
Which is cheaper, CRCA or VOO?
VOO has the lower expense ratio (0.03%).
Should I own both CRCA and VOO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.